Dong et al. further reported that pretreatment with Ts IIA protects against cerebral infarction partially associated with the reduction of ROS-mediated NF-κB activation, leading to the inhibition of iNOS expression in the ischemic area 24 h after permanent MCAo [60]. The gene discussed is NFKB1; the disease is brain infarction.